BioSpace News Archive

Brain Hemorrhage Treatment Market: Anti-hypertensive drugs segment dominated the market

Brain hemorrhage, also called brain bleed, is a type of stroke, wherein bleeding happens in the brain.

July 29, 2020
·
5 min read
Antimicrobial Susceptibility Test Market: Antibacterial Antimicrobial Susceptibility Test to be Highly Lucrative Segment

Transparency Market Research has published a new report titled, ‘Antimicrobial Susceptibility Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

July 29, 2020
·
6 min read
Genetic Analyzers Market – Know the Key Challenges and Winning Imperatives in the Market

Analysis of genes is the strategy for research and development in the fields of genetics and molecular biology.

July 29, 2020
·
3 min read
Business

LivaNova Reports Second Quarter 2020 Results

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter ended June 30, 2020.

July 29, 2020
·
12 min read
Deals

Eargo Announces $71 Million Series E Financing

Award Winning Hearing Loss Solution with Telecare Consultation & Support Sees Accelerated Consumer Demand

July 29, 2020
·
4 min read
Pharm Country

Immunic, Inc. to Participate in Investor Conferences in August 2020

Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced management’s participation in the following investor conferences in August

July 29, 2020
·
5 min read
Policy

FDA Grants Breakthrough Therapy Designation to Merck’s Novel HIF-2α Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell Carcinoma

Reinforces Important Progress in Merck’s Oncology Pipeline to Advance Novel Therapeutic Candidates

July 29, 2020
·
6 min read
Business

G1 Therapeutics to Provide Second Quarter 2020 Corporate and Financial Update on August 5, 2020

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that it will host a webcast and conference call to provide a corporate and financial update for the second quarter of 2020 on Wednesday, August 5, 2020 at 5:00 p.m. ET.

July 29, 2020
·
1 min read
BioMidwest

Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that Karen Zaderej, chairman, CEO, and president, will present at the Canaccord Genuity 40th Annual Growth Conference.

July 29, 2020
·
2 min read
Business

ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020Conference Call Scheduled for Wednesday, August 5, 2020, at 4:30 p.m. ET

ADMA Biologics, Inc. announced the Company will host a live conference call and audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. ET, to discuss its business highlights and financial results for the second quarter ended June 30, 2020.

July 29, 2020
·
2 min read